These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36669656)

  • 1. Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody.
    Basile A; Zannella C; De Marco M; Sanna G; Franci G; Galdiero M; Manzin A; De Laurenzi V; Chetta M; Rosati A; Turco MC; Marzullo L
    Antiviral Res; 2023 Mar; 211():105546. PubMed ID: 36669656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
    Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    Nchioua R; Schundner A; Kmiec D; Prelli Bozzo C; Zech F; Koepke L; Graf A; Krebs S; Blum H; Frick M; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Jun; 96(11):e0059422. PubMed ID: 35543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spike protein mediated membrane fusion during SARS-CoV-2 infection.
    Li X; Yuan H; Li X; Wang H
    J Med Virol; 2023 Jan; 95(1):e28212. PubMed ID: 36224449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syncytia formation by SARS-CoV-2-infected cells.
    Buchrieser J; Dufloo J; Hubert M; Monel B; Planas D; Rajah MM; Planchais C; Porrot F; Guivel-Benhassine F; Van der Werf S; Casartelli N; Mouquet H; Bruel T; Schwartz O
    EMBO J; 2020 Dec; 39(23):e106267. PubMed ID: 33051876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
    Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
    J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
    Narayana SK; Helbig KJ; McCartney EM; Eyre NS; Bull RA; Eltahla A; Lloyd AR; Beard MR
    J Biol Chem; 2015 Oct; 290(43):25946-59. PubMed ID: 26354436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.
    Wrensch F; Winkler M; Pöhlmann S
    Viruses; 2014 Sep; 6(9):3683-98. PubMed ID: 25256397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
    Jocher G; Grass V; Tschirner SK; Riepler L; Breimann S; Kaya T; Oelsner M; Hamad MS; Hofmann LI; Blobel CP; Schmidt-Weber CB; Gokce O; Jakwerth CA; Trimpert J; Kimpel J; Pichlmair A; Lichtenthaler SF
    EMBO Rep; 2022 Jun; 23(6):e54305. PubMed ID: 35527514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
    Prelli Bozzo C; Nchioua R; Volcic M; Koepke L; Krüger J; Schütz D; Heller S; Stürzel CM; Kmiec D; Conzelmann C; Müller J; Zech F; Braun E; Groß R; Wettstein L; Weil T; Weiß J; Diofano F; Rodríguez Alfonso AA; Wiese S; Sauter D; Münch J; Goffinet C; Catanese A; Schön M; Boeckers TM; Stenger S; Sato K; Just S; Kleger A; Sparrer KMJ; Kirchhoff F
    Nat Commun; 2021 Jul; 12(1):4584. PubMed ID: 34321474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation.
    Rajah MM; Bernier A; Buchrieser J; Schwartz O
    J Mol Biol; 2022 Mar; 434(6):167280. PubMed ID: 34606831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2.
    Zhang C; Meng X; Zhao H
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.